Literature DB >> 27556342

Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production.

Katharina J Geh1, Madlen Hubert1, Gerhard Winter1.   

Abstract

Gelatine nanoparticles (GNPs) are biodegradable and biocompatible drug delivery systems with excellent clinical performances. A two-step desolvation is commonly used for their preparation, although this methodology has several shortcomings: lack of reproducibility, small scales and low yields. A straightforward and more consistent GNP preparation approach is presented here focusing on the development of a one-step desolvation with the use of a commercially available gelatine type. Controlled stirring conditions and ultrafiltration are used to achieve large-scale production of nanoparticles of up to 2.6 g per batch. Particle size distributions are conserved and comparable to those determined for two-step desolvation on small scale. Additionally, a range of cross-linking agents is examined for their effectiveness in stabilising GNPs as an alternative to glutaraldehyde. Glyceraldehyde demonstrated outstanding properties, which led to high colloidal stability. This approach optimises the manufacturing process and the scale-up of the production capacity, providing a clear potential for future applications.

Entities:  

Keywords:  AF4; Gelatine nanoparticles; cross-linking; one-step desolvation; scale-up

Mesh:

Substances:

Year:  2016        PMID: 27556342     DOI: 10.1080/02652048.2016.1228706

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  5 in total

1.  Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.

Authors:  Lei Deng; Timothy Z Chang; Ye Wang; Song Li; Shelly Wang; Shingo Matsuyama; Guoying Yu; Richard W Compans; Jian-Dong Li; Mark R Prausnitz; Julie A Champion; Bao-Zhong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-31       Impact factor: 11.205

Review 2.  Universal influenza vaccines: from viruses to nanoparticles.

Authors:  Ye Wang; Lei Deng; Sang-Moo Kang; Bao-Zhong Wang
Journal:  Expert Rev Vaccines       Date:  2018-11-02       Impact factor: 5.217

3.  Immunomodulatory asthma therapy in the equine animal model: A dose-response study and evaluation of a long-term effect.

Authors:  John Klier; Carolin Bartl; Sabine Geuder; Katharina J Geh; Sven Reese; Lutz S Goehring; Gerhard Winter; Heidrun Gehlen
Journal:  Immun Inflamm Dis       Date:  2019-05-29

Review 4.  Protein-Based Nanoparticles as Drug Delivery Systems.

Authors:  Seyoung Hong; Dong Wook Choi; Hong Nam Kim; Chun Gwon Park; Wonhwa Lee; Hee Ho Park
Journal:  Pharmaceutics       Date:  2020-06-29       Impact factor: 6.321

5.  Highly Efficient Synthesis of Type B Gelatin and Low Molecular Weight Chitosan Nanoparticles: Potential Applications as Bioactive Molecule Carriers and Cell-Penetrating Agents.

Authors:  Cristina Gonzalez-Melo; Andres J Garcia-Brand; Valentina Quezada; Luis H Reyes; Carolina Muñoz-Camargo; Juan C Cruz
Journal:  Polymers (Basel)       Date:  2021-11-24       Impact factor: 4.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.